Healthcare -
Biotechnology - NASDAQ - US
$ 6.47
-0.919 %
$ 277 M
Market Cap
-11.55
P/E
DMAC - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss DMAC - DiaMedica Therapeutics Inc.
6 K
LAST VALUE
45.52%
2 YEAR CAGR
17.61%
5 YEAR CAGR
8.74%
10 YEAR CAGR